Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Aranda, E; Aparicio, J; Bilbao, JI; Alfonso, PG; Maurel, J; Rodriguez, J; Sangro, B; Vieitez, JM; Feliu, J.

Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases

Future Oncology. 2017; 13(23): 2065-2082 Nº de citas: 7 [doi:10.2217/fon-2017-0220]

Espinosa, E; Marquez-Rodas, I; Soria, A; Berrocal, A; Manzano, JL; Gonzalez-Cao, M; Martin-Algarra, S.

Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM)

Annals of Translational Medicine. 2017; 5(19): Nº de citas: 20 [doi:10.21037/atm.2017.08.10]

Gonzalez-Cao, M; Berrocal, A; Puig, S; Karachaliou, N; De Matos-Arruda, L; Seoane, J; Escors, D; Alvarez, C; Vaque, JP; Prat, A; Wellbrock, C; Arozarena, I; Marquez-Rodas, I; Espinosa, E; Molina, MA; Puertolas, T; Juan-Otero, M; Malagrida, R; Jantus-Lewintre, E; Soriano, V; Arance, A; Manzano, JL; Lorigan, P; Gajewski, TF; Rosell, R; Martin-Algarra, S; Spanish Melanoma Grp GEM.

Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)

Annals of Translational Medicine. 2017; 5(19): [doi:10.21037/atm.2017.06.36]

Soria, A; Manzano, JL; Berrocal, A; Espinosa, E; Marquez-Rodas, I; Gonzalez-Cao, M; Martin-Algarra, S.

Highlights of the season 2016-2017 by the Spanish Melanoma Group (GEM)

Annals of Translational Medicine. 2017; 5(19): [doi:10.21037/atm.2017.06.37]

Lopez-Tarruella, S; Jerez, Y; Marquez-Rodas, I; Echavarria, I; Martin, M.

Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer

Future Oncology. 2017; 13(24): 2137-2149 Nº de citas: 7 [doi:10.2217/fon-2017-0183]

Provencio, M; Royuela, A; Torrente, M; Pollan, M; Gomez-Codina, J; Sabin, P; Llanos, M; Guma, J; Quero, C; Blasco, A; Aguiar, D; Garcia-Arroyo, FR; Lavernia, J; Martinez, N; Morales, M; Saenz-Cusi, A; Rodriguez, D; Calvo, V; de la Cruz-Merino, L; de la Cruz, MA; Rueda, A; Spanish Lymphoma Oncology Grp.

Prognostic Value of Event-Free Survival at 12 and 24 Months and Long-Term Mortality for Non-Hodgkin Follicular Lymphoma Patients: A Study Report From the Spanish Lymphoma Oncology Group

CANCER. 2017; 123(19): 3709-3716 Nº de citas: 23 [doi:10.1002/cncr.30795]

Ocana, A; Gil-Martin, M; Martin, M; Rojo, F; Antolin, S; Guerrero, A; Trigo, JM; Munoz, M; Pandiella, A; Diego, NG; Bezares, S; Caballero, R; Carrasco, E; Urruticoechea, A.

A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study

Oncotarget. 2017; 8(42): 73144-73153 Nº de citas: 17 [doi:10.18632/oncotarget.17113]

Fonseca, PJ; Carmona-Bayonas, A; Hernandez, R; Custodio, A; Cano, JM; Lacalle, A; Echavarria, I; Macias, I; Mangas, M; Visa, L; Buxo, E; Mancenido, FA; Viudez, A; Pericay, C; Azkarate, A; Ramchandani, A; Lopez, C; de Castro, EM; Montes, AF; Longo, F; Bayona, RS; Limon, ML; Diaz-Serrano, A; Carnicero, AM; Arias, D; Cerda, P; Rivera, F; Vieitez, JM; Canovas, MS; Garrido, M; Gallego, J; AGAMENON Study Grp.

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

BRITISH JOURNAL OF CANCER. 2017; 117(6): 775-782 Nº de citas: 81 [doi:10.1038/bjc.2017.245]

Cohn, AL; Yoshino, T; Heinemann, V; Obermannova, R; Bodoky, G; Prausova, J; Garcia-Carbonero, R; Ciuleanu, T; Garcia-Alfonso, P; Portnoy, DC; Van Cutsem, E; Yamazaki, K; Clingan, PR; Polikoff, J; Lonardi, S; O'Brien, LM; Gao, L; Yang, L; Ferry, D; Nasroulah, F; Tabernero, J.

Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial

CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2017; 80(3): 599-608 Nº de citas: 18 [doi:10.1007/s00280-017-3380-z]

Santos, C; Azuara, D; Garcia-Carbonero, R; Alfonso, PG; Carrato, A; Elez, ME; Gomez, A; Losa, F; Montagut, C; Massuti, B; Navarro, V; Varela, M; Lopez-Doriga, A; Moreno, V; Valladares, M; Manzano, JL; Vieitez, JM; Aranda, E; Sanjuan, X; Tabernero, J; Capella, G; Salazar, R.

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer

MOLECULAR CANCER THERAPEUTICS. 2017; 16(9): 1999-2007 Nº de citas: 11 [doi:10.1158/1535-7163.MCT-17-0153]

Pellicer, M; Garcia-Gonzalez, X; Garcia, MI; Blanco, C; Garcia-Alfonso, P; Robles, L; Gravalos, C; Rueda, D; Martinez, J; Pachon, V; Longo, F; Martinez, V; Iglesias, I; Salvador, S; Sanjurjo, M; Lopez-Fernandez, LA.

Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity

PHARMACOGENOMICS. 2017; 18(13): 1215-1223 Nº de citas: 11 [doi:10.2217/pgs-2017-0118]

Provencio, M; Rodriguez, M; Cantos, B; Sabin, P; Quero, C; Garcia-Arroyo, FR; Rueda, A; Maximiano, C; Rodriguez-Abreu, D; Sanchez, A; Silva, J; Garcia, V.

mRNA in exosomas as a liquid biopsy in non-Hodgkin Lymphoma: a multicentric study by the Spanish lymphoma oncology group

Oncotarget. 2017; 8(31): 50949-50957 Nº de citas: 39 [doi:10.18632/oncotarget.16435]

Jimenez-Fonseca, P; Carmona-Bayonas, A; Calderon, C; Boj, JF; Font, C; Lecumberri, R; Monreal, M; Martin, AJM; Otero, R; Rubio, A; Ruiz-Artacho, P; Fernandez, CS; Colome, E; Segura, PP.

FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence

CLINICAL & TRANSLATIONAL ONCOLOGY. 2017; 19(8): 997-1009 Nº de citas: 10 [doi:10.1007/s12094-017-1632-3]

Davies, MA; Saiag, P; Robert, C; Grob, JJ; Flaherty, KT; Arance, A; Chiarion-Sileni, V; Thomas, L; Lesimple, T; Mortier, L; Moschos, SJ; Hogg, D; Marquez-Rodas, I; Del Vecchio, M; Lebbe, C; Meyer, N; Zhang, Y; Huang, YJ; Mookerjee, B; Long, GV.

Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

LANCET ONCOLOGY. 2017; 18(7): 863-873 Nº de citas: 583 [doi:10.1016/S1470-2045(17)30429-1]

Mendizabal, E; De Leon-Luis, J; Gomez-Hidalgo, NR; Joigneau, L; Pintado, P; Rincon, P; Ortega, V; Lizarraga, S.

Maternal and perinatal outcomes in pregnancy-associated melanoma. Report of two cases and a systematic literature review

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 2017; 214: 131-139 Nº de citas: 14 [doi:10.1016/j.ejogrb.2017.04.023]

Prat, A; Lluch, A; Turnbull, AK; Dunbier, AK; Calvo, L; Albanell, J; de la Haba-Rodriguez, J; Arcusa, A; Chacon, JI; Sanchez-Rovira, P; Plazaola, A; Munoz, M; Pare, L; Parker, JS; Ribelles, N; Jimenez, B; Bin Aiderus, AA; Caballero, R; Adamo, B; Dowsett, M; Carrasco, E; Martin, M; Dixon, JM; Perou, CM; Alba, E.

A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse

CLINICAL CANCER RESEARCH. 2017; 23(12): 3035-3044 Nº de citas: 41 [doi:10.1158/1078-0432.CCR-16-2092]

Custodio, A; Carmona-Bayonas, A; Jimenez-Fonseca, P; Sanchez, ML; Viudez, A; Hernandez, R; Cano, JM; Echavarria, I; Pericay, C; Mangas, M; Visa, L; Buxo, E; Garcia, T; Palomo, AR; Mancenido, FA; Lacalle, A; Macias, I; Azkarate, A; Ramchandani, A; Montes, AF; Lopez, C; Longo, F; Bayona, RS; Limon, ML; Diaz-Serrano, A; Hurtado, A; Madero, R; Gomez, C; Gallego, J.

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab

BRITISH JOURNAL OF CANCER. 2017; 116(12): 1526-1535 Nº de citas: 48 [doi:10.1038/bjc.2017.122]

Hidalgo, M; Alvarez, R; Gallego, J; Guillen-Ponce, C; Laquente, B; Macarulla, T; Munoz, A; Salgado, M; Vera, R; Adeva, J; Ales, I; Arevalo, S; Blazquez, J; Calsina, A; Carmona, A; de Madaria, E; Diaz, R; Diez, L; Fernandez, T; de Paredes, BG; Gallardo, ME; Gonzalez, I; Hernando, O; Jimenez, P; Lopez, A; Lopez, C; Lopez-Rios, F; Martin, E; Martinez, J; Martinez, A; Montans, J; Pazo, R; Plaza, JC; Peiro, I; Reina, JJ; Sanjuanbenito, A; Yaya, R; Carrato, A.

Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

CLINICAL & TRANSLATIONAL ONCOLOGY. 2017; 19(6): 667-681 Nº de citas: 22 [doi:10.1007/s12094-016-1594-x]